Analysis of 5 year experience of home dialysis as a treatment modality for patients with end-stage renal failure.
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001201:Ascites / Q000209:etiology; D001806:Blood Urea Nitrogen; D002118:Calcium / Q000097:blood; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology; D003404:Creatinine / Q000097:blood; D003928:Diabetic Nephropathies / Q000628:therapy; D005260:Female; D006333:Heart Failure / Q000209:etiology; D006437:Hemodialysis, Home / Q000009:adverse effects; D006505:Hepatitis / Q000209:etiology; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000534:rehabilitation / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000209:etiology; D010493:Pericarditis / Q000209:etiology; D010758:Phosphorus / Q000097:blood; D014652:Vascular Diseases / Q000209:etiology
D000959:Antihypertensive Agents; D010758:Phosphorus; D003404:Creatinine; D000469:Alkaline Phosphatase; D002118:Calcium